PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)
Part of paid clinical trials in Tampa, Florida.
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study ID
- NCT07638150
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Mediterranean Diet — OTHERA two-week cyclic menu (14 unique days of meals repeated) approach will be used for the Mediterranean diet intervention. Participants will be provided with 3 meals a day and receive daily snacks to consume.
Study Details
This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.
Key Dates
- Start date
- Aug 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Mediterranean DietParticipants receive all meals and snacks for 4 weeks, following a standardized Mediterranean diet meal plan.
Primary Outcome Measure
Feasibility of Enrollment [ Time Frame: Up to 1 year ]
Central Contacts
- Alissa Pena813-745-7710
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Moffitt Cancer Center | Tampa | Florida | 33612 | Tiffany Carson, PhD, MPH (PRINCIPAL_INVESTIGATOR) Vivian Doerr, PhD (SUB_INVESTIGATOR) Sylvia Crowder, PhD (SUB_INVESTIGATOR) Doratha Byrd, PhD (SUB_INVESTIGATOR) Melissa Mallory, MD (SUB_INVESTIGATOR) Steven Sutton, PhD (SUB_INVESTIGATOR) |
Find similar trials in Tampa, FL
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)Recruiting · University of California, San Francisco · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama